title: Primary prevention: HBV vaccination in hemodialysis unit.
abstract: The authors evaluated the response rate to HBV vaccination in 27 dialyzed patients. In the 1st stage, the response was 70.37%; nonresponder patients (n = 8) were treated with thymostimulin and revaccinated. The total percentage increased to 85.18%. In order to restore a normal response, the authors suggest to treat nonresponder patients with thymostimulin before revaccination.
authors.affiliation: Servizio Emodialisi di Castrovillari, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Sapio
authors.forename: A
authors.initials: A
authors.lastname: Bonifati
authors.forename: A
authors.initials: A
authors.lastname: Confessore
authors.forename: M
authors.initials: M
authors.lastname: Gatti
authors.forename: I
authors.initials: I
authors.lastname: Maimone
authors.forename: M P
authors.initials: MP
authors.lastname: Minella
authors.forename: L
authors.initials: L
authors.lastname: Scarpino
authors.forename: C
authors.initials: C
authors.lastname: D'Alessandro
mesh_terms: D000328:Adult; D005260:Female; D006509:Hepatitis B / Q000517:prevention & control; D006510:Hepatitis B Antibodies / Q000097:blood; D017325:Hepatitis B Vaccines; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D013949:Thymus Extracts / Q000008:administration & dosage; D014614:Vaccines, Synthetic / Q000008:administration & dosage; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D013949:Thymus Extracts; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines; C031407:thymostimulin